Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genenta Science SpA Sponsored ADR ( (GNTA) ) has issued an update.
Genenta Science S.p.A., an Italian biotechnology company listed on Nasdaq, has spent over ten years building market recognition around the Genenta name, which has become closely linked to its corporate identity and visibility with global investors. The brand’s established value appears central to the company’s positioning as it considers how to expand its corporate purpose under recent Italian Golden Power legislation.
On March 23, 2026, Genenta’s board revoked the call for an Extraordinary Shareholders’ Meeting that had been scheduled for March 25–26, 2026 to approve a corporate name change to Saentra Forge S.p.A. The board cited the current strength of the Genenta brand and the early-stage status of its newly extended corporate purpose, indicating that while a future rebranding remains a strategic objective, any switch to the Saentra Forge name will be delayed until the new positioning is more fully developed and recognized in the market.
The most recent analyst rating on (GNTA) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Genenta Science SpA Sponsored ADR stock, see the GNTA Stock Forecast page.
More about Genenta Science SpA Sponsored ADR
Genenta Science S.p.A. is an Italian biotechnology company based in Milan and listed on Nasdaq in the U.S. Its Genenta-branded operations have built more than a decade of recognition, value, and market presence, making the corporate name an important asset tied to its identity and positioning with investors and other stakeholders.
Average Trading Volume: 1,091,562
Technical Sentiment Signal: Sell
Current Market Cap: $12.74M
Find detailed analytics on GNTA stock on TipRanks’ Stock Analysis page.